BACKGROUND: There are limited data on the burden of disease posed by influenza in low- and middle-income countries. Furthermore, most estimates of influenza disease burden worldwide rely on passive sentinel surveillance at health clinics and hospitals that lack accurate population denominators. METHODS: We documented influenza incidence, seasonality, health-system utilization with influenza illness, and vaccination coverage through active community-based surveillance in 4 ecologically distinct regions of Peru over 6 years. Approximately 7200 people in 1500 randomly selected households were visited 3 times per week. Naso- and oropharyngeal swabs were collected from persons with influenza-like illness and tested for influenza virus by real-time reverse-transcription polymerase chain reaction. RESULTS: We followed participants for 35353 person-years (PY). The overall incidence of influenza was 100 per 1000 PY (95% confidence interval [CI], 97-104) and was highest in children aged 2-4 years (256/1000 PY [95% CI, 236-277]). Seasonal incidence trends were similar across sites, with 61% of annual influenza cases occurring during the austral winter (May-September). Of all participants, 44 per 1000 PY (95% CI, 42-46) sought medical care, 0.7 per 1000 PY (95% CI, 0.4-1.0) were hospitalized, and 1 person died (2.8/100000 PY). Influenza vaccine coverage was 27% among children aged 6-23 months and 26% among persons aged ≥65 years. CONCLUSIONS: Our results indicate that 1 in 10 persons develops influenza each year in Peru, with the highest incidence in young children. Active community-based surveillance allows for a better understanding of the true burden and seasonality of disease that is essential to plan the optimal target groups, timing, and cost of national influenza vaccination programs. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: There are limited data on the burden of disease posed by influenza in low- and middle-income countries. Furthermore, most estimates of influenza disease burden worldwide rely on passive sentinel surveillance at health clinics and hospitals that lack accurate population denominators. METHODS: We documented influenza incidence, seasonality, health-system utilization with influenza illness, and vaccination coverage through active community-based surveillance in 4 ecologically distinct regions of Peru over 6 years. Approximately 7200 people in 1500 randomly selected households were visited 3 times per week. Naso- and oropharyngeal swabs were collected from persons with influenza-like illness and tested for influenza virus by real-time reverse-transcription polymerase chain reaction. RESULTS: We followed participants for 35353 person-years (PY). The overall incidence of influenza was 100 per 1000 PY (95% confidence interval [CI], 97-104) and was highest in children aged 2-4 years (256/1000 PY [95% CI, 236-277]). Seasonal incidence trends were similar across sites, with 61% of annual influenza cases occurring during the austral winter (May-September). Of all participants, 44 per 1000 PY (95% CI, 42-46) sought medical care, 0.7 per 1000 PY (95% CI, 0.4-1.0) were hospitalized, and 1 person died (2.8/100000 PY). Influenza vaccine coverage was 27% among children aged 6-23 months and 26% among persons aged ≥65 years. CONCLUSIONS: Our results indicate that 1 in 10 persons develops influenza each year in Peru, with the highest incidence in young children. Active community-based surveillance allows for a better understanding of the true burden and seasonality of disease that is essential to plan the optimal target groups, timing, and cost of national influenza vaccination programs. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
community cohort; healthcare-seeking behavior; household-based; influenza; seasonality
Authors: Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell Journal: Lancet Date: 2011-11-10 Impact factor: 79.321
Authors: Nusrat Homaira; Stephen P Luby; William A Petri; Raija Vainionpaa; Mustafizur Rahman; Kamal Hossain; Cynthia B Snider; Mahmudur Rahman; A S M Alamgir; Farzina Zesmin; Masud Alam; Emily S Gurley; Rashid Uz Zaman; Tasnim Azim; Dean D Erdman; Alicia M Fry; Joseph Bresee; Marc-Alain Widdowson; Rashidul Haque; Eduardo Azziz-Baumgartner Journal: PLoS One Date: 2012-02-22 Impact factor: 3.240
Authors: David Hodgson; Marc Baguelin; Edwin van Leeuwen; Jasmina Panovska-Griffiths; Mary Ramsay; Richard Pebody; Katherine E Atkins Journal: Lancet Public Health Date: 2017-02
Authors: Yeny Tinoco; Hugo Razuri; Ernesto J Ortiz; Jorge Gomez; Marc-Alain Widdowson; Timothy Uyeki; Victor Alberto Laguna-Torres; Tadeusz J Kochel; Robert H Gilman; Joel M Montgomery Journal: Influenza Other Respir Viruses Date: 2009-11 Impact factor: 4.380
Authors: Alba María Ropero-Álvarez; Nathalie El Omeiri; Hannah Jane Kurtis; M Carolina Danovaro-Holliday; Cuauhtémoc Ruiz-Matus Journal: Hum Vaccin Immunother Date: 2016-05-19 Impact factor: 3.452
Authors: Gabriela Salmon-Mulanovich; Mark P Simons; Carmen Flores-Mendoza; Steev Loyola; María Silva; Matthew Kasper; Hugo R Rázuri; Luis Enrique Canal; Mariana Leguia; Daniel G Bausch; Allen L Richards Journal: Am J Trop Med Hyg Date: 2019-06 Impact factor: 2.345
Authors: Juan Alonso Leon-Abarca; Arianna Portmann-Baracco; Mayte Bryce-Alberti; Carlos Ruiz-Sánchez; Roberto Alfonso Accinelli; Jorge Soliz; Gustavo Francisco Gonzales Journal: PLoS One Date: 2021-08-03 Impact factor: 3.240
Authors: Meredith G Wesley; Giselle Soto; Carmen Sofia Arriola; Miriam Gonzales; Gabriella Newes-Adeyi; Candice Romero; Vic Veguilla; Min Z Levine; Maria Silva; Jill M Ferdinands; Fatimah S Dawood; Sue B Reynolds; Avital Hirsch; Mark Katz; Eduardo Matos; Eduardo Ticona; Juan Castro; Maria Castillo; Eduar Bravo; Angela Cheung; Rachel Phadnis; Emily Toth Martin; Yeny Tinoco; Joan Manuel Neyra Quijandria; Eduardo Azziz-Baumgartner; Mark G Thompson Journal: Influenza Other Respir Viruses Date: 2020-04-05 Impact factor: 4.380
Authors: Rakhee S Palekar; Melissa A Rolfes; C Sofia Arriola; Belsy O Acosta; Patricia Alberto Guidos; Xiomara Badilla Vargas; Christina Bancej; Juliana Barbosa Ramirez; Elsa Baumeister; Alfredo Bruno; Maria Agüeda Cabello; Jufu Chen; Paula Couto; Francisco J De Paula Junior; Rodrigo Fasce; Walquiria Ferreira de Almeida; Victor E Fiesta Solorzano; Carlos Flores Ramírez; Natalia Goñi; Yadira Isaza de Moltó; Jenny Lara; Diana C Malo; José L Medina Osis; Homer Mejía; Lourdes Moreno Castillo; Desiree Mustaquim; Andrea Nwosu; Jenny Ojeda; Antonio Paredes Samoya; Paola A Pulido; Hector M Ramos Hernandez; Rudvelinda Rivera Lopez; Angel Rodriguez; Myriam Saboui; Hilda Salazar Bolanos; Adrián Santoro; Jose Eduardo Silvera; Paulina Sosa; Viviana Sotomayor; Lourdes Suarez; Marta Von Horoch; Eduardo Azziz-Baumgartner Journal: PLoS One Date: 2019-09-06 Impact factor: 3.240